Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kiniksa Pharmaceuticals International (KNSA) Change in Inventory (2021 - 2026)

Kiniksa Pharmaceuticals International filings provide 6 years of Change in Inventory readings, the most recent being $18.2 million for Q1 2026.

  • On a quarterly basis, Change in Inventory rose 524.82% to $18.2 million in Q1 2026 year-over-year; TTM through Mar 2026 was $51.1 million, a 1080.46% increase, with the full-year FY2025 number at $28.5 million, up 699.64% from a year prior.
  • Change in Inventory hit $18.2 million in Q1 2026 for Kiniksa Pharmaceuticals International, up from $13.5 million in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $26.1 million in Q2 2025 to a low of -$6.8 million in Q3 2025.
  • Median Change in Inventory over the past 5 years was $1.8 million (2023), compared with a mean of $4.1 million.
  • Biggest five-year swings in Change in Inventory: tumbled 583.23% in 2022 and later skyrocketed 1322.14% in 2024.
  • Kiniksa Pharmaceuticals International's Change in Inventory stood at $7.0 million in 2022, then dropped by 20.62% to $5.5 million in 2023, then plummeted by 141.81% to -$2.3 million in 2024, then soared by 682.86% to $13.5 million in 2025, then skyrocketed by 35.17% to $18.2 million in 2026.
  • The last three reported values for Change in Inventory were $18.2 million (Q1 2026), $13.5 million (Q4 2025), and -$6.8 million (Q3 2025) per Business Quant data.